CN101912570B - Medicinal composition for treating rheumatism and preparation method thereof - Google Patents
Medicinal composition for treating rheumatism and preparation method thereof Download PDFInfo
- Publication number
- CN101912570B CN101912570B CN2010102411363A CN201010241136A CN101912570B CN 101912570 B CN101912570 B CN 101912570B CN 2010102411363 A CN2010102411363 A CN 2010102411363A CN 201010241136 A CN201010241136 A CN 201010241136A CN 101912570 B CN101912570 B CN 101912570B
- Authority
- CN
- China
- Prior art keywords
- radix
- weight portion
- weight portions
- rhizoma
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating rheumatism. The medicinal composition comprises medicaments such as prepared common monkshood mother root, prepared kusnezoff monkshood root, clematis root, sappan wood, turmeric, Chinese angelica, Chinese taxillus twig, mulberry twig, dahurian angelica root, erythrina indica lam, Philippine flemingia root, obscured homalomena rhizome, loofah sponge, rhizoma drynariae, beautiful sweetgum fruit and the like. The conventional auxiliary materials are added into the medicinal composition by the conventional process to obtain clinically-acceptable pills, tablets, powder, capsules, particles or paste. The medicinal composition of the invention has the effects of dispersing pathogenic wind, removing obstruction in channels to relieve pain, cooling blood and eliminating swelling and has remarkable curative effect on the rheumatism.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to rheumatismal pharmaceutical composition of a kind of treatment and preparation method thereof.
Background technology
Rheumatism is a kind of commonly encountered diseases, and how because of receiving damp and hot wind-dryness deeply, the cold-damp mist is attacked due to the human body, and ancient times, well-known doctor's Zhang Zhongjing was mentioned in " Medical Treasures of the Golden Chamber " " the most all over the body pain of patient, this rheumatism ".This shows that rheumatism is a kind of systemic disease, it mainly involves connective tissue; Most patient has the pathological changes of joint, muscle, and is relevant with the crucial immunological abnormality of body, belongs to autoimmune disease; It has comprised numerous disease; Like rheumatic, rheumatoid arthritis, dry syndrome, rheumatic hyperosteogeny etc.During morbidity, that patient's skin and joint take place is tingle, pain is red and swollen, and the whole body is uncomfortable, lassitude, and brothers forget oneself, and vim and vigour are weak, and are obstinate unusual, are difficult for curing.For this treatment of diseases; Chinese and western medicine common method and medicine are a lot, but curative effect is undesirable, and untoward reaction is all arranged during medication and after the drug withdrawal; The toxic and side effects that has is also very big; At present Chinese medicine comprises two kinds of medicine for external use and oral medicine, and oral medicine has certain toxic and side effects to human body, and gastrointestinal tract is also had certain stimulation.And general medicine for external use is difficult for absorbing, and curative effect is not obvious.
Summary of the invention
The object of the invention is to provide a kind of treatment rheumatismal pharmaceutical composition, another object of the present invention is to provide a kind of treatment rheumatismal preparation of drug combination method.
The present invention realizes through following technical scheme:
The crude drug of pharmaceutical composition of the present invention consists of:
Radix Aconiti Preparata 25-75 weight portion Radix Aconiti Kusnezoffii Preparata 25-75 weight portion Radix Clematidis 30-90 weight portion
Lignum Sappan 30-90 weight portion Rhizoma Curcumae Longae 30-90 weight portion Radix Angelicae Sinensis 15-45 weight portion
Herba Taxilli 30-90 weight portion Ramulus Mori 30-90 weight portion Radix Angelicae Dahuricae 25-75 weight portion
Cortex erythrinae 25-75 weight portion Radix Flemingiae Philippinensis 25-75 weight portion Rhizoma Homalomenae 25-75 weight portion
Retinervus Luffae Fructus 25-75 weight portion Rhizoma Drynariae 40-120 weight portion Fructus Liquidambaris 25-75 weight portion
Mahonia bealei (Fort.) Carr. 20-60 weight portion Cortex Fissistigmatis bracteolati Radicis 25-75 weight portion Squama Manis 15-45 weight portion
Radix Cynanchi Paniculati 25-75 weight portion Herba Lycopodii 25-75 weight portion Radix Aconiti Lateralis Preparata 15-45 weight portion
Radix Achyranthis Bidentatae 15-45 weight portion Fructus Chaenomelis 15-45 weight portion Scorpio 15-45 weight portion
Cortex Eucommiae 25-75 weight portion Olibanum (processed) 25-75 weight portion Myrrha (processed) 25-75 weight portion
Scolopendra 10-30 weight portion Rhizoma Corydalis 25-75 weight portion Radix Glycyrrhizae 15-45 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Aconiti Preparata 50 weight portion Radix Aconiti Kusnezoffii Preparatas 50 weight portion Radix Clematidis 60 weight portions
Lignum Sappan 60 weight portion Rhizoma Curcumae Longaes 60 weight portion Radix Angelicae Sinensis 30 weight portions
The Herba Taxilli 60 weight portion Ramulus Moris 60 weight portion Radixs Angelicae Dahuricae 50 weight portions
Cortex erythrinae 50 weight portion Radix Flemingiae Philippinensiss 50 weight portion Rhizoma Homalomenaes 50 weight portions
Retinervus Luffae Fructus 50 weight portion Rhizoma Drynariae 80 weight portion Fructus Liquidambaris 50 weight portions
Mahonia bealei (Fort.) Carr. 40 weight portion Cortex Fissistigmatis bracteolati Radiciss 50 weight portion Squama Maniss 30 weight portions
Radix Cynanchi Paniculati 50 weight portion Herba Lycopodiis 50 weight portion Radix Aconiti Lateralis Preparata 30 weight portions
Radix Achyranthis Bidentatae 30 weight portion Fructus Chaenomeliss 50 weight portion Scorpios 30 weight portions
The Cortex Eucommiae 50 weight portion Olibanum (processed)s 50 weight portion Myrrha (processed)s 50 weight portions
Scolopendra 20 weight portion Rhizoma Corydalis 50 weight portion Radix Glycyrrhizaes 30 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Aconiti Preparata 20 weight portion Radix Aconiti Kusnezoffii Preparatas 70 weight portion Radix Clematidis 35 weight portions
Lignum Sappan 85 weight portion Rhizoma Curcumae Longaes 35 weight portion Radix Angelicae Sinensis 40 weight portions
The Herba Taxilli 35 weight portion Ramulus Moris 85 weight portion Radixs Angelicae Dahuricae 30 weight portions
Cortex erythrinae 70 weight portion Radix Flemingiae Philippinensiss 30 weight portion Rhizoma Homalomenaes 70 weight portions
Retinervus Luffae Fructus 30 weight portion Rhizoma Drynariae 110 weight portion Fructus Liquidambaris 30 weight portions
Mahonia bealei (Fort.) Carr. 55 weight portion Cortex Fissistigmatis bracteolati Radiciss 30 weight portion Squama Maniss 20 weight portions
Radix Cynanchi Paniculati 70 weight portion Herba Lycopodiis 30 weight portion Radix Aconiti Lateralis Preparata 40 weight portions
Radix Achyranthis Bidentatae 20 weight portion Fructus Chaenomeliss 40 weight portion Scorpios 20 weight portions
The Cortex Eucommiae 70 weight portion Olibanum (processed)s 30 weight portion Myrrha (processed)s 70 weight portions
Scolopendra 15 weight portion Rhizoma Corydalis 70 weight portion Radix Glycyrrhizaes 40 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Aconiti Preparata 70 weight portion Radix Aconiti Kusnezoffii Preparatas 30 weight portion Radix Clematidis 85 weight portions
Lignum Sappan 40 weight portion Rhizoma Curcumae Longaes 85 weight portion Radix Angelicae Sinensis 20 weight portions
The Herba Taxilli 85 weight portion Ramulus Moris 35 weight portion Radixs Angelicae Dahuricae 70 weight portions
Cortex erythrinae 30 weight portion Radix Flemingiae Philippinensiss 70 weight portion Rhizoma Homalomenaes 30 weight portions
Retinervus Luffae Fructus 70 weight portion Rhizoma Drynariae 50 weight portion Fructus Liquidambaris 70 weight portions
Mahonia bealei (Fort.) Carr. 30 weight portion Cortex Fissistigmatis bracteolati Radiciss 70 weight portion Squama Maniss 20 weight portions
Radix Cynanchi Paniculati 70 weight portion Herba Lycopodiis 30 weight portion Radix Aconiti Lateralis Preparata 40 weight portions
Radix Achyranthis Bidentatae 20 weight portion Fructus Chaenomeliss 40 weight portion Scorpios 20 weight portions
The Cortex Eucommiae 70 weight portion Olibanum (processed)s 30 weight portion Myrrha (processed)s 70 weight portions
Scolopendra 15 weight portion Rhizoma Corydalis 70 weight portion Radix Glycyrrhizaes 20 weight portions.
There is the patient of gastric ulcer also to add Typhonium flagelliforme (Lodd.) Blume 25-75 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-120 weight portion, Radix Et Rhizoma Rhei 25-75 weight portion, Radix Ophiopogonis 15-45 weight portion; Preferred form and proportioning is respectively Typhonium flagelliforme (Lodd.) Blume 50 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 weight portions, Radix Et Rhizoma Rhei 50 weight portions, Radix Ophiopogonis 30 weight portion; Typhonium flagelliforme (Lodd.) Blume 30 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 110 weight portions, Radix Et Rhizoma Rhei 30 weight portions, Radix Ophiopogonis 40 weight portion; Typhonium flagelliforme (Lodd.) Blume 70 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 45 weight portions, Radix Et Rhizoma Rhei 70 weight portions, Radix Ophiopogonis 20 weight portion.
Pharmaceutical composition of the present invention adds pharmaceutically conventional adjuvant according to common process and processes in pill, tablet, powder, capsule, granule or the unguentum of clinical acceptance any.
Pharmaceutical composition of the present invention have dispel the wind, removing obstruction in the collateral to relieve pain, removing heat from blood, repercussive effect, for the treatment rheumatism evident in efficacy.
Following experimental example is used to further specify but is not limited to the present invention
Experimental example:
Medicine composite for curing 200 routine patient's clinical observations of the present invention:
One, clinical data:
Among the medicine composite for curing 200 routine patients of the present invention, all be the male, minimum 29 years old of age, maximum 80 years old.In 200 examples, cure 190 people, 10 people that take a turn for the better, invalid not discovery at present.
Two, Therapeutic Method
Prescription:
Radix Aconiti Preparata 50g Radix Aconiti Kusnezoffii Preparata 50g Radix Clematidis 60g
Lignum Sappan 60g Rhizoma Curcumae Longae 60g Radix Angelicae Sinensis 30g
Herba Taxilli 60g Ramulus Mori 60g Radix Angelicae Dahuricae 50g
Cortex erythrinae 50g Radix Flemingiae Philippinensis 50g Rhizoma Homalomenae 50g
Retinervus Luffae Fructus 50g Rhizoma Drynariae 80g Fructus Liquidambaris 50g
Mahonia bealei (Fort.) Carr. 40g Cortex Fissistigmatis bracteolati Radicis 50g Squama Manis 30g
Radix Cynanchi Paniculati 50g Herba Lycopodii 50g Radix Aconiti Lateralis Preparata 30g
Radix Achyranthis Bidentatae 30g Fructus Chaenomelis 50g Scorpio 30g
Cortex Eucommiae 50g Olibanum (processed) 50g Myrrha (processed) 50g
Scolopendra 20g Rhizoma Corydalis 50g Radix Glycyrrhizae 30g.
Method for preparing: superfine end is ground in medicine-feeding, process the honeyed pill of clinical acceptance according to the conventional adjuvant that common process adds pharmaceutically.
There is the patient of gastric ulcer also to add Typhonium flagelliforme (Lodd.) Blume 50g, Pseudobulbus Bletillae (Rhizoma Bletillae) 80g, Radix Et Rhizoma Rhei 50g, Radix Ophiopogonis 30g, processes the honeyed pill of clinical acceptance according to the conventional adjuvant that common process adds pharmaceutically.
Instructions of taking: obey 10 grams (about 50 balls) a day 2 times, one after each meal, is generally taken first quarter moon to 30 and day can be alleviated or stop pain at 6 months one courses of treatment at every turn; When having the patient of gastric ulcer to take this medicine ball, suitable decrement (about 40 balls).
Attention: period in a medicine, can not take following food:
1, all plucks of fasting (comprising " blood and so on ").
2, all seafoods.
3, cattle, sheep, Carnis Canitis, cock, Cyprinus carpio.
4, can not have the beer, drink Chinese liquor less or do not drink Chinese liquor as far as possible.
5, eat and do not eat as far as possible bean food less.
Three, criterion of therapeutical effect
Cure: clinical symptom disappearance, arthralgia disappears, and arthroncus disappears, and no limitation of activity, climate such as overcast and rainy, as to blow change and no longer recur no low grade fever.
Take a turn for the better: clinical symptoms alleviates to some extent.
Invalid: characteristic of disease does not have significant change before and after the treatment.
Four, therapeutic outcome
Medicine composite for curing patient 200 examples of the present invention are cured 190 examples, 10 examples that take a turn for the better, and invalid 0 example, cure rate is 95%, improvement rate is: 5%, inefficiency is 0%, total effective rate 100%.
Five, model case:
Wu * *: the man, 48 years old, live the urban district, changde, hunan province; The hotel staff, before 4 years because of foot big toe joint, position red and swollen heat pain such as ankle joint and articulations digitorum manus and in March, 2008 here; The above-mentioned position of readme aching as needle stabbing, walk with difficulty, through using the Drug therapy of the embodiment of the invention 3, alleviate after ten days January surplus do not see sore; Advise it to continue to use up and heal, do not send out so far.
Poplar * *, woman, 65 years old, people from Guangdong Province; Teacher because of foot big toe pain 8 years, is illustrated in special trip in 2006 through the patient and rides on a train here to go to a doctor, and sees that its affected part is red and swollen; Burning pain can not be walked, and once takes Western medicine such as " colchicine, indometacin, prednisones " in a large number and brings out gastrorrhagia; Hospitalization behind the medicine of taking the embodiment of the invention 2, is followed up a case by regular visits to so far and is not sent out.
Lee * *, man, 42 years old, people from Gongan County, Hubei; The peasant, the foot halluces outside is red and swollen, surplus the pain 5 year; Be diagnosed as uric acid disease (gout) through provincial hospital and once took medicine such as heavy dose of colchicine and had only analgesic effect in short-term, come the tablet of here upon somebody's introduction, take alleviation of pain in January six months (course of treatment) with the embodiment of the invention 4; Pain disappears basically after March, does not send out in 3 years so far, sells the agency as his place at present.
Jiang * *, man, 48 years old, people from Shantou, Guangdong, enterpriser; Because of suffering from surplus the gout 8 year in the double-legged halluces outside, and produce tophus, surgical removal tophus once, and come me to locate upon somebody's introduction, see that its walking is difficult; Pain endlessly, seafood is several years ago taken in readme in a large number, and suffers from this disease down, has no resolution through the how tame big or small hospitalize in the whole nation; Heal through 2 courses of treatment of Drug therapy of using the embodiment of the invention 1, this also is that I treat example of stubbornness of gout, and impression is arranged deeply, this side research that is worthy to be popularized really.
Following embodiment all can realize the described effect of above-mentioned experimental example
The specific embodiment
Embodiment 1:
Radix Aconiti Preparata 50g Radix Aconiti Kusnezoffii Preparata 50g Radix Clematidis 60g
Lignum Sappan 60g Rhizoma Curcumae Longae 60g Radix Angelicae Sinensis 30g
Herba Taxilli 60g Ramulus Mori 60g Radix Angelicae Dahuricae 50g
Cortex erythrinae 50g Radix Flemingiae Philippinensis 50g Rhizoma Homalomenae 50g
Retinervus Luffae Fructus 50g Rhizoma Drynariae 80g Fructus Liquidambaris 50g
Mahonia bealei (Fort.) Carr. 40g Cortex Fissistigmatis bracteolati Radicis 50g Squama Manis 30g
Radix Cynanchi Paniculati 50g Herba Lycopodii 50g Radix Aconiti Lateralis Preparata 30g
Radix Achyranthis Bidentatae 30g Fructus Chaenomelis 50g Scorpio 30g
Cortex Eucommiae 50g Olibanum (processed) 50g Myrrha (processed) 50g
Scolopendra 20g Rhizoma Corydalis 50g Radix Glycyrrhizae 30g;
Method for preparing: superfine end is ground in medicine-feeding, process the honeyed pill of clinical acceptance according to the conventional adjuvant that common process adds pharmaceutically.
Instructions of taking: obey 10 grams (about 50 balls) a day 2 times, one after each meal, is generally taken first quarter moon to 30 and day can be alleviated or stop pain at 6 months one courses of treatment at every turn.
Embodiment 2:
Radix Aconiti Preparata 50g Radix Aconiti Kusnezoffii Preparata 50g Radix Clematidis 60g
Lignum Sappan 60g Rhizoma Curcumae Longae 60g Radix Angelicae Sinensis 30g
Herba Taxilli 60g Ramulus Mori 60g Radix Angelicae Dahuricae 50g
Cortex erythrinae 50g Radix Flemingiae Philippinensis 50g Rhizoma Homalomenae 50g
Retinervus Luffae Fructus 50g Rhizoma Drynariae 80g Fructus Liquidambaris 50g
Mahonia bealei (Fort.) Carr. 40g Cortex Fissistigmatis bracteolati Radicis 50g Squama Manis 30g
Radix Cynanchi Paniculati 50g Herba Lycopodii 50g Radix Aconiti Lateralis Preparata 30g
Radix Achyranthis Bidentatae 30g Fructus Chaenomelis 50g Scorpio 30g
Cortex Eucommiae 50g Olibanum (processed) 50g Myrrha (processed) 50g
Scolopendra 20g Rhizoma Corydalis 50g Radix Glycyrrhizae 30g
Typhonium flagelliforme (Lodd.) Blume 50g Pseudobulbus Bletillae (Rhizoma Bletillae) 80g Radix Et Rhizoma Rhei 50g
Radix Ophiopogonis 30g;
Method for preparing: superfine end is ground in medicine-feeding, process the honeyed pill of clinical acceptance according to the conventional adjuvant that common process adds pharmaceutically.
Instructions of taking: obey 10 grams (about 50 balls) a day 2 times, one after each meal, is generally taken first quarter moon to 30 and day can be alleviated or stop pain at 6 months one courses of treatment at every turn; When having the patient of gastric ulcer to take this medicine ball, suitable decrement (about 40 balls).
Embodiment 3: the preparation of pill
Radix Aconiti Preparata 20g Radix Aconiti Kusnezoffii Preparata 70g Radix Clematidis 35g
Lignum Sappan 85g Rhizoma Curcumae Longae 35g Radix Angelicae Sinensis 40g
Herba Taxilli 35g Ramulus Mori 85g Radix Angelicae Dahuricae 30g
Cortex erythrinae 70g Radix Flemingiae Philippinensis 30g Rhizoma Homalomenae 70g
Retinervus Luffae Fructus 30g Rhizoma Drynariae 110g Fructus Liquidambaris 30g
Mahonia bealei (Fort.) Carr. 55g Cortex Fissistigmatis bracteolati Radicis 30g Squama Manis 20g
Radix Cynanchi Paniculati 70g Herba Lycopodii 30g Radix Aconiti Lateralis Preparata 40g
Radix Achyranthis Bidentatae 20g Fructus Chaenomelis 40g Scorpio 20g
Cortex Eucommiae 70g Olibanum (processed) 30g Myrrha (processed) 70g
Scolopendra 15g Rhizoma Corydalis 70g Radix Glycyrrhizae 40g;
Get the above-mentioned raw materials medicine, process pill according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 4: the preparation of tablet
Radix Aconiti Preparata 70g Radix Aconiti Kusnezoffii Preparata 30g Radix Clematidis 85g
Lignum Sappan 40g Rhizoma Curcumae Longae 85g Radix Angelicae Sinensis 20g
Herba Taxilli 85g Ramulus Mori 35g Radix Angelicae Dahuricae 70g
Cortex erythrinae 30g Radix Flemingiae Philippinensis 70g Rhizoma Homalomenae 30g
Retinervus Luffae Fructus 70g Rhizoma Drynariae 50g Fructus Liquidambaris 70g
Mahonia bealei (Fort.) Carr. 30g Cortex Fissistigmatis bracteolati Radicis 70g Squama Manis 20g
Radix Cynanchi Paniculati 70g Herba Lycopodii 30g Radix Aconiti Lateralis Preparata 40g
Radix Achyranthis Bidentatae 20g Fructus Chaenomelis 40g Scorpio 20g
Cortex Eucommiae 70g Olibanum (processed) 30g Myrrha (processed) 70g
Scolopendra 15g Rhizoma Corydalis 70g Radix Glycyrrhizae 20g;
Get the above-mentioned raw materials medicine, process tablet according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 5: the preparation of granule
Radix Aconiti Preparata 20g Radix Aconiti Kusnezoffii Preparata 70g Radix Clematidis 35g
Lignum Sappan 85g Rhizoma Curcumae Longae 35g Radix Angelicae Sinensis 40g
Herba Taxilli 35g Ramulus Mori 85g Radix Angelicae Dahuricae 30g
Cortex erythrinae 70g Radix Flemingiae Philippinensis 30g Rhizoma Homalomenae 70g
Retinervus Luffae Fructus 30g Rhizoma Drynariae 110g Fructus Liquidambaris 30g
Mahonia bealei (Fort.) Carr. 55g Cortex Fissistigmatis bracteolati Radicis 30g Squama Manis 20g
Radix Cynanchi Paniculati 70g Herba Lycopodii 30g Radix Aconiti Lateralis Preparata 40g
Radix Achyranthis Bidentatae 20g Fructus Chaenomelis 40g Scorpio 20g
Cortex Eucommiae 70g Olibanum (processed) 30g Myrrha (processed) 70g
Scolopendra 15g Rhizoma Corydalis 70g Radix Glycyrrhizae 40g
Typhonium flagelliforme (Lodd.) Blume 30g, Pseudobulbus Bletillae (Rhizoma Bletillae) 110g, Radix Et Rhizoma Rhei 30g, Radix Ophiopogonis 40g;
Get the above-mentioned raw materials medicine, process granule according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 6: the preparation of capsule
Radix Aconiti Preparata 70g Radix Aconiti Kusnezoffii Preparata 30g Radix Clematidis 85g
Lignum Sappan 40g Rhizoma Curcumae Longae 85g Radix Angelicae Sinensis 20g
Herba Taxilli 85g Ramulus Mori 35g Radix Angelicae Dahuricae 70g
Cortex erythrinae 30g Radix Flemingiae Philippinensis 70g Rhizoma Homalomenae 30g
Retinervus Luffae Fructus 70g Rhizoma Drynariae 50g Fructus Liquidambaris 70g
Mahonia bealei (Fort.) Carr. 30g Cortex Fissistigmatis bracteolati Radicis 70g Squama Manis 20g
Radix Cynanchi Paniculati 70g Herba Lycopodii 30g Radix Aconiti Lateralis Preparata 40g
Radix Achyranthis Bidentatae 20g Fructus Chaenomelis 40g Scorpio 20g
Cortex Eucommiae 70g Olibanum (processed) 30g Myrrha (processed) 70g
Scolopendra 15g Rhizoma Corydalis 70g Radix Glycyrrhizae 20g
Typhonium flagelliforme (Lodd.) Blume 70g, Pseudobulbus Bletillae (Rhizoma Bletillae) 45g, Radix Et Rhizoma Rhei 70g, Radix Ophiopogonis 20g;
Get the above-mentioned raw materials medicine, process capsule according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 7: the preparation of unguentum
Radix Aconiti Preparata 70g Radix Aconiti Kusnezoffii Preparata 30g Radix Clematidis 85g
Lignum Sappan 40g Rhizoma Curcumae Longae 85g Radix Angelicae Sinensis 20g
Herba Taxilli 85g Ramulus Mori 35g Radix Angelicae Dahuricae 70g
Cortex erythrinae 30g Radix Flemingiae Philippinensis 70g Rhizoma Homalomenae 30g
Retinervus Luffae Fructus 70g Rhizoma Drynariae 50g Fructus Liquidambaris 70g
Mahonia bealei (Fort.) Carr. 30g Cortex Fissistigmatis bracteolati Radicis 70g Squama Manis 20g
Radix Cynanchi Paniculati 70g Herba Lycopodii 30g Radix Aconiti Lateralis Preparata 40g
Radix Achyranthis Bidentatae 20g Fructus Chaenomelis 40g Scorpio 20g
Cortex Eucommiae 70g Olibanum (processed) 30g Myrrha (processed) 70g
Scolopendra 15g Rhizoma Corydalis 70g Radix Glycyrrhizae 20g
Typhonium flagelliforme (Lodd.) Blume 70g, Pseudobulbus Bletillae (Rhizoma Bletillae) 45g, Radix Et Rhizoma Rhei 70g, Radix Ophiopogonis 20g;
Get the above-mentioned raw materials medicine, process unguentum according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 8: the preparation of powder
Radix Aconiti Preparata 50g Radix Aconiti Kusnezoffii Preparata 50g Radix Clematidis 60g
Lignum Sappan 60g Rhizoma Curcumae Longae 60g Radix Angelicae Sinensis 30g
Herba Taxilli 60g Ramulus Mori 60g Radix Angelicae Dahuricae 50g
Cortex erythrinae 50g Radix Flemingiae Philippinensis 50g Rhizoma Homalomenae 50g
Retinervus Luffae Fructus 50g Rhizoma Drynariae 80g Fructus Liquidambaris 50g
Mahonia bealei (Fort.) Carr. 40g Cortex Fissistigmatis bracteolati Radicis 50g Squama Manis 30g
Radix Cynanchi Paniculati 50g Herba Lycopodii 50g Radix Aconiti Lateralis Preparata 30g
Radix Achyranthis Bidentatae 30g Fructus Chaenomelis 50g Scorpio 30g
Cortex Eucommiae 50g Olibanum (processed) 50g Myrrha (processed) 50g
Scolopendra 20g Rhizoma Corydalis 50g Radix Glycyrrhizae 30g.
Get the above-mentioned raw materials medicine, process powder according to the conventional adjuvant that common process adds pharmaceutically.
Claims (10)
1. treat rheumatismal pharmaceutical composition for one kind, it is characterized in that the crude drug of this pharmaceutical composition consists of:
2. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
3. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
4. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
5. treat rheumatismal pharmaceutical composition for one kind, it is characterized in that the crude drug of this pharmaceutical composition consists of:
Typhonium flagelliforme (Lodd.) Blume 25-75 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-120 weight portion, Radix Et Rhizoma Rhei 25-75 weight portion, Radix Ophiopogonis the 15-45 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 50 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 weight portions, Radix Et Rhizoma Rhei 50 weight portions, Radix Ophiopogonis 30 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 30 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 110 weight portions, Radix Et Rhizoma Rhei 30 weight portions, Radix Ophiopogonis 40 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 70 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 45 weight portions, Radix Et Rhizoma Rhei 70 weight portions, Radix Ophiopogonis 20 weight portion.
6. pharmaceutical composition as claimed in claim 5 is characterized in that the crude drug of this pharmaceutical composition consists of:
Typhonium flagelliforme (Lodd.) Blume 25-75 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-120 weight portion, Radix Et Rhizoma Rhei 25-75 weight portion, Radix Ophiopogonis the 15-45 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 50 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 weight portions, Radix Et Rhizoma Rhei 50 weight portions, Radix Ophiopogonis 30 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 30 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 110 weight portions, Radix Et Rhizoma Rhei 30 weight portions, Radix Ophiopogonis 40 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 70 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 45 weight portions, Radix Et Rhizoma Rhei 70 weight portions, Radix Ophiopogonis 20 weight portion.
7. pharmaceutical composition as claimed in claim 5 is characterized in that the crude drug of this pharmaceutical composition consists of:
Typhonium flagelliforme (Lodd.) Blume 25-75 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-120 weight portion, Radix Et Rhizoma Rhei 25-75 weight portion, Radix Ophiopogonis the 15-45 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 50 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 weight portions, Radix Et Rhizoma Rhei 50 weight portions, Radix Ophiopogonis 30 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 30 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 110 weight portions, Radix Et Rhizoma Rhei 30 weight portions, Radix Ophiopogonis 40 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 70 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 45 weight portions, Radix Et Rhizoma Rhei 70 weight portions, Radix Ophiopogonis 20 weight portion.
8. pharmaceutical composition as claimed in claim 5 is characterized in that the crude drug of this pharmaceutical composition consists of:
Typhonium flagelliforme (Lodd.) Blume 25-75 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 40-120 weight portion, Radix Et Rhizoma Rhei 25-75 weight portion, Radix Ophiopogonis the 15-45 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 50 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 weight portions, Radix Et Rhizoma Rhei 50 weight portions, Radix Ophiopogonis 30 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 30 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 110 weight portions, Radix Et Rhizoma Rhei 30 weight portions, Radix Ophiopogonis 40 weight portion; Or Typhonium flagelliforme (Lodd.) Blume 70 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 45 weight portions, Radix Et Rhizoma Rhei 70 weight portions, Radix Ophiopogonis 20 weight portion.
9. like the arbitrary described pharmaceutical composition of claim 1-8, it is characterized in that this pharmaceutical composition adds pharmaceutically conventional adjuvant according to common process and processes in pill, tablet, powder, capsule, granule or the unguentum of clinical acceptance any.
10. like the application of the arbitrary described pharmaceutical composition of claim 1-8 in the rheumatismal medicine of preparation treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102411363A CN101912570B (en) | 2010-07-29 | 2010-07-29 | Medicinal composition for treating rheumatism and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102411363A CN101912570B (en) | 2010-07-29 | 2010-07-29 | Medicinal composition for treating rheumatism and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101912570A CN101912570A (en) | 2010-12-15 |
| CN101912570B true CN101912570B (en) | 2012-07-04 |
Family
ID=43320317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102411363A Expired - Fee Related CN101912570B (en) | 2010-07-29 | 2010-07-29 | Medicinal composition for treating rheumatism and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101912570B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083488B (en) * | 2013-03-01 | 2014-08-27 | 赣南医学院 | Traditional Chinese medical composition for treating bone disease as well as preparation thereof |
| CN103656506A (en) * | 2013-12-11 | 2014-03-26 | 青岛中科菲力工程技术研发有限公司 | Application powder for removing toxicity and dredging collaterals |
-
2010
- 2010-07-29 CN CN2010102411363A patent/CN101912570B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 姚血明.类风湿关节炎的中医药治疗进展.《辽宁中医药大学学报》.2009,第11卷(第10期),191-193. * |
| 彭跃钢.类风湿性关节炎中医药治疗进展.《广西中医药》.2006,第29卷(第4期),1-3. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101912570A (en) | 2010-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101797347B (en) | Traditional Chinese medicinal composition for treating gastrointestinal tract and preparation thereof | |
| CN101491572A (en) | Medicine for treating calculus and preparation method thereof | |
| CN103893639A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN103330806B (en) | Drug for treatment of rheumatoid arthritis | |
| CN104474473A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation and preparation method thereof | |
| CN101912570B (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN102526275B (en) | Pharmaceutical for curing gout and preparation method thereof | |
| CN101380457B (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
| CN102240351B (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
| CN101129677A (en) | Quick-effective pill for hemorrhoid | |
| CN103690673A (en) | Formula capsules for treating rheumatism | |
| CN102716381B (en) | Traditional Chinese medicine used for treating appendicitis | |
| CN103041362B (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN102488781A (en) | Traditional Chinese medicine composition for treating wind-damp-cold arthralgia | |
| CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
| CN103933277A (en) | Tibetan drug for treating gout disease | |
| CN103961490A (en) | Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof | |
| CN103212013A (en) | Chinese medicinal composition for treating epigastric pain | |
| CN102188548A (en) | Medicinal compositions for treating psoriasis and preparation method thereof | |
| CN102389545A (en) | Traditional Chinese medicine for treating diabetic gout | |
| CN102085350A (en) | Medicament for treating arthritis and preparation method thereof | |
| CN101120966A (en) | Capsule medicine for treating intestinal ascariasis | |
| CN101422540A (en) | Medicine for curing stomatocase | |
| CN105056008A (en) | Traditional Chinese medicine preparation for treating gastrectasia and dyspepsia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20170729 |